Long Term Outcome of Extracorporeal Membrane Oxygenation Patients in China

Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine,China;

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03345758

Acronym

ECMO

Enrollment

Registered

2017-11-17

Start date

2017-08-01

Completion date

2023-12-30

Last updated

2022-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extracorporeal Membrane Oxygenation, Long-term Outcome

Keywords

respiratory failure, circulatory failure

Brief summary

Outcomes and Long-term Quality-of-life of Patients requiring Extracorporeal Membrane Oxygenation are not known in china. A prospective study survey will be performed to assess the long-term outcome of these patients.

Detailed description

Patients admitted to ICUs and treated with extracorporeal membrane oxygenation from March 1,2015 to March 1,2019 were screened . Pre-Ecmo clinical parameters(diagnose,APACHE-II, SOFA,indications,expected mortality) and related treatment conditions(duration of ICU stay, duration of ECMO,duration of mechanical ventilation,ventilation conditions,prone ventilation,ECMO complications )will be used to assess the severity and curative effect of these patients.Short Form-36 Health Status Questionnaire,EuroQol-5 Dimensions and St. George's Respiratory Questionnaire(SGRQ) will deliver in these survivors ,which are used to assess the physical and mental health ,as well as the social adaptation. Finally a comprehensive assessment will be obtained to describe the outcomes and long-term quality-of-life of patients treated With ECMO.

Interventions

OTHERoutcome

telephone to patients to finish SF-36 (the MOS item short from health survey,SF-36)，EQ-5D(EuroQol-5 Dimensions,EQ-5D)， AMT-4（Abbreviated Mental Test-4,AMT-4）and MMSE（Mini-mental State Examination,MMSE） to make assessments of their physical and mental health, cognitive function and social adaptation after discharge

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* require extracorporeal membrane oxygenation

Exclusion criteria

* irreversible disease

Design outcomes

Primary

Measure	Time frame	Description
survival rate	August,1,2017-March,1,2020	survival rate at discharge

Secondary

Measure	Time frame	Description
Quality of live	August,1,2017-March,1,2020	Questionnaire：mobility，personal care (washing/dressing)，usual activities，Pain/discomfort，Anxiety/depression
Cognitive function	August,1,2017-March,1,2020	MMSE Questionnaire

Countries

China

Contacts

Primary Contactling liu, MD

liulingdoctor@126.com13851435472

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026